Clinical Trial Update: A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This Phase 1 two-part single ascending-dose study evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of DS-7309 in healthy volunteers and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DS-7309

Snippet

Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED